Hypomagnesemia is common in critical care and associated with cardiac arrhythmia, increased need for ventilator support, and increased length of stay and mortality.1
Real-time serial measurement of ionized magnesium (iMg) to guide Mg therapy has been demonstrated to improve outcomes and reduce length of stay for critically ill patients.2
This brief seminar will examine the essential role of iMg monitoring in cardiothoracic surgery and in critical illness such as sepsis, as well as why iMg is a better clinical and diagnostic marker than total Mg.
A new critical care analyzer that provides real-time, bedside iMg results—along with gases, electrolytes, and metabolites including optional creatinine and BUN for acute kidney injury—will be presented.
Learning Objectives
Presenter
Bogdan Milojkovic, MD, Global Director, Medical and Scientific Affairs, Nova Biomedical
All seminars start at 6 PM
Oct 8 – Houston, TX Oct 10 – Burbank, CA Oct 30 – Kansas City, MO |
Nov 5 – Long Island, NY Nov 6 – Baltimore, MD Nov 7 – Dearborn, MI Nov 19 – Tampa, FL (at capacity) |
This seminar offers 1 hour of P.A.C.E, CERP, and CRCE continuing education credits.
1. Yeh DD et al. Total and ionized magnesium testing in the surgical intensive care unit – Opportunities for improved laboratory and pharmacy utilization. J Crit Care 2017;42:147-151.
2. Wilkes NJ. Correction of ionized plasma magnesium during cardiopulmonary bypass reduces the risk of postoperative cardiac arrhythmia. Anesth Analg 2002;95:828-834.